Start Here

If you are new to The BioCompound, begin here.
The publication is built around one system: the three-sleeve compounding framework.

Step 1 — Understand the Framework

Every company is evaluated against five criteria:

1.     Approved, scaling product

2.     Monopoly or near-monopoly position

3.     Multi-year revenue visibility

4.     Cash runway without new capital raises

5.     Reduced binary risk

Companies are assigned to one of three sleeves:

•       7–10 Year Sleeve

•       2–3 Year Sleeve

•       Watch List

Step 2 — See the Framework Applied

Public visitors can request the Vertex Pharmaceuticals (VRTX) demonstration deep dive by email.

The VRTX demonstration shows how the framework evaluates a completed compounding biotech. It excludes allocation percentage, model dollar amount, company-level monitoring triggers, cross-sleeve comparison, and portfolio context.

Step 3 — Understand the Publishing Rhythm

- Tuesday: The Weekly Thesis / monthly public-release introduction

- Thursday: Framework Spotlight

- First Tuesday of each month: paid member memo

Step 4 — Choose How You Want to Follow the Framework

Public
Watch every YouTube video and read public posts, framework explainers, sector pieces, and the public scorecard.

Standalone
Buy a full deep dive on any publicly released company for $35.

Sequential Access subscription
Get full access to each full deep dive, published monthly, plus monthly research memos and follow-up analysis.

Full Library Access
Get immediate access to the entire current company BioSleeve library, including names not yet publicly released, plus monthly research memos and follow-up analysis.